BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC)
CUSIP: 07725L102
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Ordinary shares, par value $0.0001 per share
- Shares outstanding
- 1,385,160,313
- Total 13F shares
- 56,111,399
- Share change
- +486,439
- Total reported value
- $20,367,209,544
- Put/Call ratio
- 149%
- Price per share
- $363.00
- Number of holders
- 242
- Value change
- +$187,897,220
- Number of buys
- 120
- Number of sells
- 112
Quarterly Holders Quick Answers
What is CUSIP 07725L102?
CUSIP 07725L102 identifies ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 07725L102:
Top shareholders of ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.84%
|
11,668,897
|
$4,004,649,000 | — | 30 Jun 2021 | |
| AMGEN INC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
18,943,802
|
$3,419,356,261 | — | 10 Sep 2021 | |
| Capital International Investors |
13F
|
Company |
0.43%
|
5,939,650
|
$2,042,640,000 | — | 30 Jun 2021 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.4%
|
5,472,259
|
$1,878,025,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
0.31%
|
4,290,468
|
$1,472,446,000 | — | 30 Jun 2021 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.31%
|
4,272,178
|
$1,466,169,000 | — | 30 Jun 2021 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.28%
|
3,857,960
|
$1,324,013,000 | — | 30 Jun 2021 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.2%
|
2,748,056
|
$943,105,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.18%
|
2,530,327
|
$868,382,000 | — | 30 Jun 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.18%
|
2,479,808
|
$851,046,000 | — | 30 Jun 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.07%
|
941,916
|
$323,257,000 | — | 30 Jun 2021 | |
| Howard Liang |
3/4/5
|
CFO & Chief Strategy Officer |
—
class O/S missing
|
1,553,149
|
$322,615,606 | — | 28 Jun 2021 | |
| Capital International, Inc./CA/ |
13F
|
Company |
0.07%
|
937,859
|
$321,864,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
886,488
|
$304,234,000 | — | 30 Jun 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.06%
|
850,000
|
$291,712,000 | — | 30 Jun 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
0.06%
|
764,188
|
$262,262,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.04%
|
582,093
|
$199,768,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
312,910
|
$107,387,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
273,730
|
$93,940,000 | — | 30 Jun 2021 | |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.02%
|
243,692
|
$83,633,000 | — | 30 Jun 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0.02%
|
232,710
|
$79,864,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
226,961
|
$77,892,000 | — | 30 Jun 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
213,305
|
$73,204,000 | — | 30 Jun 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.01%
|
200,000
|
$68,638,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
199,000
|
$68,295,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
196,817
|
$67,068,000 | — | 30 Jun 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.01%
|
179,082
|
$61,459,152 | — | 30 Jun 2021 | |
| USS Investment Management Ltd |
13F
|
Company |
0.01%
|
168,000
|
$57,718,000 | — | 30 Jun 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.01%
|
165,346
|
$56,745,000 | — | 30 Jun 2021 | |
| Capital Bank & Trust Co |
13F
|
Company |
0.01%
|
164,964
|
$56,614,000 | — | 30 Jun 2021 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.01%
|
158,574
|
$54,421,000 | — | 30 Jun 2021 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.01%
|
156,561
|
$53,730,000 | — | 30 Jun 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
153,442
|
$52,660,000 | — | 30 Jun 2021 | |
| Casdin Capital, LLC |
13F
|
Company |
0.01%
|
150,000
|
$51,479,000 | — | 30 Jun 2021 | |
| Fiera Capital Corp |
13F
|
Company |
0.01%
|
147,798
|
$50,723,000 | — | 30 Jun 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.01%
|
130,595
|
$44,819,000 | — | 30 Jun 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
115,436
|
$39,616,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
114,502
|
$39,296,000 | — | 30 Jun 2021 | |
| Swiss National Bank |
13F
|
Company |
0.01%
|
112,985
|
$38,775,000 | — | 30 Jun 2021 | |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP |
13F
|
Company |
0.01%
|
112,946
|
$38,762,000 | — | 30 Jun 2021 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.01%
|
111,889
|
$38,399,000 | — | 30 Jun 2021 | |
| Capital International Sarl |
13F
|
Company |
0.01%
|
98,054
|
$33,651,000 | — | 30 Jun 2021 | |
| Amundi |
13F
|
Individual |
0.01%
|
93,582
|
$32,116,000 | — | 30 Jun 2021 | |
| Bridgewater Associates, LP |
13F
|
Company |
0.01%
|
86,046
|
$29,530,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.01%
|
84,647
|
$29,050,000 | — | 30 Jun 2021 | |
| Bellevue Group AG |
13F
|
Company |
0.01%
|
84,300
|
$28,931,000 | — | 30 Jun 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.01%
|
83,886
|
$28,788,000 | — | 30 Jun 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.01%
|
82,251
|
$28,227,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
82,094
|
$28,173,000 | — | 30 Jun 2021 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
81,429
|
$27,946,000 | — | 30 Jun 2021 |
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q3 2021
As of 30 Sep 2021,
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) was held by
242 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,111,399 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Capital International Investors, HHLR ADVISORS, LTD., BAILLIE GIFFORD & CO, FMR LLC, PRIMECAP MANAGEMENT CO/CA/, Invesco Ltd., Temasek Holdings (Private) Ltd, BlackRock Inc., and CAPITAL INTERNATIONAL INC /CA/.
This page lists
244
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
259
Q3 2021 holders
242
Holder diff
-17
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.